Panel Discussion: WAR STORIES, moderated by Gerald Brady from Silicon Valley Bank
Month: June 2012
Symposium 2012: Fundraising Trends panel
Panel on why firms are raising so many funds, and so many are outside of the US? Stephen Ziff from Coller Capital moderated the panel.
Symposium 2012: Future Leaders panel
Panel on the next generation of corporate venturing leaders, moderated by Neil Foster from Baker Botts.
Symposium 2012: Justin Adams, ex-BP
Justin Adams, ex-head of Emerging Business and Ventures at BP, reflects on corporate venturing and its future models.
Symposium 2012: Jon Moulton, Better Capital
Keynote Speech: Jon Moulton, Founder and Chairman, Better Capital.
Symposium 2012: Global and Sector panel
Panel on how can firms deal with a globally-distributed, cross-sectoral innovation landscape, moderated by Andrew Gaule from Corven.
Symposium 2012: Gary Dushnitsky, LBS
Gary Dushnitsky from the London Business School gives a keynote about how corporate venturing is helping.
Symposium 2012: Government panel
Panel on the role of governments to help the ecosystem, moderated by Erik Vermeulen from Philips and Tilburg University Law School.
Symposium 2012: Venture connectivity panel
Global Corporate Venturing Panel Discussion on Venture Connectivity, moderated by Erik Sebusch from CMEA Capital.
Symposium 2012: David Willetts, MP
The Rt Hon David Willetts, MP for Havant, gives a Power-spot presentation.
Symposium 2012: David Lawson, P&G
Keynote presentation by David Lawson, open innovation manager at Procter and Gamble.
Symposium 2012: Healthcare Q&A
Edited highlights from last month’s Keynote Healthcare Q&A at the Global Corporate Venturing Symposium 2012 with Merck’s William Taranto and Cleveland Clinic’s Tom Thornton.
Google Ventures snags SCVNGR
Google’s corporate venturing unit helps SCVNGR, maker of the eponymous mobile game, and LevelUp, an app which lets you pay with your phone, raise $12m.
JJDC, Kaiser Permanente like Astute
Kaiser Permanente and Johnson & Johnson’s corporate venturing units have helped Astute Medical, a biomarker-based medical diagnostics firm, raise $40.4m. Kaiser Permanente and Johnson & Johnson Development Corporation were joined in the series C by venture firms MPM Capital, De Novo Ventures, Delphi Ventures and Domain Associates. Last year Astute Medical, a US-based provider of… Continue reading JJDC, Kaiser Permanente like Astute